Target type: biologicalprocess
Any process where the infecting virus reduces the levels of viral proteins in a cell. [GOC:ai]
Viruses, as obligate intracellular parasites, rely on host cellular machinery for their replication. To efficiently utilize host resources and avoid triggering immune responses, viruses have evolved intricate mechanisms to regulate the levels of their own proteins within infected cells. Negative regulation of viral protein levels is a crucial aspect of this process.
Several mechanisms contribute to this negative regulation, including:
1. **Transcriptional Regulation:** Viruses often encode regulatory proteins that bind to specific DNA sequences within their genome, repressing transcription of viral genes. This can control the production of viral proteins at the very first step of gene expression.
2. **Post-Transcriptional Regulation:**
* **RNA Degradation:** Viral mRNAs can be targeted for degradation by host cellular mechanisms, such as the RNA interference (RNAi) pathway. This limits the availability of mRNA templates for protein synthesis.
* **mRNA Stability:** Viral mRNAs can be regulated by their own proteins or host factors that influence their stability. Shortening the lifespan of mRNA transcripts reduces the overall protein production.
3. **Translational Regulation:**
* **Ribosome Binding:** Viruses may encode proteins that directly compete with viral mRNAs for ribosome binding sites, slowing down translation and ultimately protein synthesis.
* **Translation Initiation Factors:** Viruses can manipulate host factors involved in translation initiation, such as eIF4E, to either inhibit or promote the translation of specific viral mRNAs.
4. **Post-Translational Regulation:**
* **Protein Degradation:** Viral proteins can be targeted for degradation by host proteasomes or lysosomes. This process is often regulated by ubiquitination, a process that marks proteins for destruction.
* **Protein Stability:** Viral proteins may contain intrinsic properties that make them inherently unstable, leading to their rapid degradation.
5. **Viral Counter-Defense Mechanisms:** Viruses may also possess strategies to evade host antiviral defenses. Some viruses encode proteins that inhibit the expression or function of host proteins involved in negative regulation of viral protein levels. This enables them to maintain a steady supply of viral proteins.
By employing these diverse mechanisms, viruses fine-tune the expression of their proteins, optimizing their replication and minimizing the chances of triggering host immune responses. This delicate balance is crucial for the success of viral infections.'
"
Protein | Definition | Taxonomy |
---|---|---|
Signal transducer and activator of transcription 1-alpha/beta | A signal transducer and activator of transcription 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P42224] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
suramin sodium | suramin sodium : An organic sodium salt that is the hexasodium salt of suramin. It is an FDA approved drug for African sleeping sickness and river blindness. | organic sodium salt | angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug |
epigallocatechin gallate | (-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis) | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite |
nsc 74859 | NSC 74859: inhibits Stat3 binding activity; structure in first source S3I-201 : An amidobenzoic acid obtained by formal condensation of the carboxy group of [(4-methylbenzene-1-sulfonyl)oxy]acetic acid with the amino group of 4-amino-2-hydroxybenzoic acid. | amidobenzoic acid; monohydroxybenzoic acid; tosylate ester | STAT3 inhibitor |
nf 449 | |||
5,15-diphenylporphine | 5,15-diphenylporphine: structure in first source | ||
guttiferone k | guttiferone K: antiproliferative compound of Rheedia calcicola from the Madagascar rain forest; structure in first source |